These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 14556257

  • 1. Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.
    Stürmer M, Berger A, Doerr HW.
    J Med Virol; 2003 Dec; 71(4):475-9. PubMed ID: 14556257
    [Abstract] [Full Text] [Related]

  • 2. RNA extraction prior to HIV-1 resistance detection using Line Probe Assay (LiPA): comparison of three methods.
    Labayru C, Eiros JM, Hernández B, de Lejarazu RO, Torres AR.
    J Clin Virol; 2005 Apr; 32(4):265-71. PubMed ID: 15780803
    [Abstract] [Full Text] [Related]

  • 3. Magnetic-silica based nucleic acid extraction for Human Immunodeficiency Virus Type-1 drug-resistance testing in low viremic patients.
    Milia MG, Allice T, Gregori G, Mussino S, Orofino G, Bonora S, Ghisetti V.
    J Clin Virol; 2010 Jan; 47(1):8-12. PubMed ID: 19914863
    [Abstract] [Full Text] [Related]

  • 4. Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load.
    Stelzl E, Troppan KT, Winkler M, Korn K, Kessler HH.
    J Virol Methods; 2010 Sep; 168(1-2):152-4. PubMed ID: 20471425
    [Abstract] [Full Text] [Related]

  • 5. Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system.
    Alp A, Hascelik G.
    Diagn Microbiol Infect Dis; 2009 Apr; 63(4):365-71. PubMed ID: 19232859
    [Abstract] [Full Text] [Related]

  • 6. Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia.
    Mackie N, Dustan S, McClure MO, Weber JN, Clarke JR.
    J Virol Methods; 2004 Aug; 119(2):73-8. PubMed ID: 15158587
    [Abstract] [Full Text] [Related]

  • 7. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, Mandaliya K, Plum J, Verhofstede C.
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH, Wong KH, Chan K, Lam HY, Lee SS, Li P, Lee MP, Tsang DN, Zheng BJ, Yuen KY, Yam WC.
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [Abstract] [Full Text] [Related]

  • 9. Performance of the TruGene human immunodeficiency virus type 1 genotyping kit and OpenGene DNA sequencing system on clinical samples diluted to approximately 100 copies per milliliter.
    Gale HB, Kan VL, Shinol RC.
    Clin Vaccine Immunol; 2006 Feb; 13(2):235-8. PubMed ID: 16467331
    [Abstract] [Full Text] [Related]

  • 10. Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
    Beddows S, Galpin S, Kazmi SH, Ashraf A, Johargy A, Frater AJ, White N, Braganza R, Clarke J, McClure M, Weber JN.
    J Med Virol; 2003 Jul; 70(3):337-42. PubMed ID: 12766994
    [Abstract] [Full Text] [Related]

  • 11. Genotypic antiretroviral drug resistance testing at low viral loads in the UK.
    Cane PA, Kaye S, Smit E, Tilston P, Kirk S, Shepherd J, Hopkins M, Zhang H, Geretti AM.
    HIV Med; 2008 Oct; 9(8):673-6. PubMed ID: 18557948
    [Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of the Cobas Amplicor HIV-1 Monitor Ultrasensitive Test, the new Cobas AmpliPrep/Cobas Amplicor HIV-1 Monitor Ultrasensitive Test and the Versant HIV RNA 3.0 assays for quantitation of HIV-1 RNA in plasma samples.
    Berger A, Scherzed L, Stürmer M, Preiser W, Doerr HW, Rabenau HF.
    J Clin Virol; 2005 May; 33(1):43-51. PubMed ID: 15797364
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts.
    Ziemniak C, George-Agwu A, Moss WJ, Ray SC, Persaud D.
    J Virol Methods; 2006 Sep; 136(1-2):238-47. PubMed ID: 16828172
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ, Bissett SL, Myers RE, Beddows S, Edwards S, Cane PA, Pillay D.
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [Abstract] [Full Text] [Related]

  • 19. Quantitation of HIV-1 RNA levels in plasma and CSF of asymptomatic HIV-1 infected patients from South India using a TaqMan real time PCR assay.
    Kamat A, Ravi V, Desai A, Satishchandra P, Satish KS, Borodowsky I, Subbakrishna DK, Kumar M.
    J Clin Virol; 2007 May; 39(1):9-15. PubMed ID: 17368087
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the new VERSANT HIV-1 RNA 1.0 Assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA.
    Troppan KT, Stelzl E, Violan D, Winkler M, Kessler HH.
    J Clin Virol; 2009 Sep; 46(1):69-74. PubMed ID: 19576845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.